A basic science view of acute kidney injury biomarkers
Open accessThe DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
Over the last decade, significant progress has been made in the identification and validation of novel biomarkers as well as refinements in the use of serum creatinine as a marker of kidney function. These advances have taken advantage of laboratory investigations, which have identified these novel molecules that serve important biological functions in the pathogenesis of acute kidney injury (AKI). As we advance and validate these markers for clinical studies in AKI, we recognize that they serve not only to improve our understanding of AKI, but they could also serve as potential targets for the treatment of AKI. This review will underscore the biological basis of specific biomarkers that will contribute to the advancement in the treatment and outcomes of AKI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G., Levin, A., & the Acute Kidney Injury Network (2007) · Critical Care · doi:10.1186/cc5713 · Cited by 7,048
Bellomo, R., Ronco, C., Kellum, J. A., Mehta, R. L., Palevsky, P., & workgroup, T. A. (2004) · Critical Care · doi:10.1186/cc2872 · Cited by 6,781
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Metabolomics—the link between genotypes and phenotypes
Fiehn, O. (2002) · Plant Molecular Biology · doi:10.1023/a:1013713905833 · Cited by 3,445 · cited 1×
“Metabolomics refers to the study of the metabolite pool that exists within a cell, tissue or biofluid under a particular set of conditions [117], whereas metabonomics has been defined as the quantitative measurement of the dynamic metabolic response of living systems to pathophysiological stimuli or genetic modificati…”
BackgroundMetabolomics — the link between genotypes and phenotypes
Fiehn, O. (2002) · Functional Genomics · doi:10.1007/978-94-010-0448-0_11 · Cited by 3,167
Cloning of a new cytokine that induces IFN-γ production by T cells
Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,600
Mishra, J., Dent, C., Tarabishi, R., Mitsnefes, M. M., Ma, Q., Kelly, C., Ruff, S. M., Zahedi, K., Shao, M., Bean, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74811-x · Cited by 2,394
Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury
Han, W. K., Bailly, V., Abichandani, R., Thadhani, R., & Bonventre, J. V. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00433.x · Cited by 1,929
Mishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J., & Devarajan, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088027.54400.c6 · Cited by 1,749 · cited 3×
“An interest in NGAL as a clinical biomarker came after it was found that NGAL was markedly upregulated in the kidney tissue in the mouse models of renal IRI and cisplatin, and these changes were accompanied by the presence of urinary NGAL which preceded the rise in serum creatinine [71, 72].”
BackgroundMetabolomics--the link between genotypes and phenotypes.
Fiehn, O. (2002) · PubMed · Cited by 1,517
Cited by
Ostermann, M., Zarbock, A., Goldstein, S., Kashani, K., Macedo, E., Murugan, R., Bell, M., Forni, L., Guzzi, L., Joannidis, M., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.19209 · Cited by 677
Acute kidney injury 2016: diagnosis and diagnostic workup
Ostermann, M., & Joannidis, M. (2016) · Critical Care · doi:10.1186/s13054-016-1478-z · Cited by 391
Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease
Gilbert, R. E. (2017) · Diabetes · doi:10.2337/db16-0796 · Cited by 362
Sepsis-Associated Acute Kidney Injury
Manrique-Caballero, C. L., Del Rio-Pertuz, G., & Gomez, H. (2021) · Critical Care Clinics · doi:10.1016/j.ccc.2020.11.010 · Cited by 312
Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption
Kashani, K., Cheungpasitporn, W., & Ronco, C. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0973 · Cited by 289
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity
Koyner, J. L., Davison, D. L., Brasha-Mitchell, E., Chalikonda, D. M., Arthur, J. M., Shaw, A. D., Tumlin, J. A., Trevino, S. A., Bennett, M. R., Kimmel, P. L., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014060535 · Cited by 283
Acute Kidney Injury after Cardiac Surgery: Prediction, Prevention, and Management
Cheruku, S. R., Raphael, J., Neyra, J. A., & Fox, A. A. (2023) · Anesthesiology · doi:10.1097/aln.0000000000004734 · Cited by 193
Lane, J. M., Delavaux, C. S., Van Koppen, L., Lu, P., Cade-Menun, B. J., Tremblay, J., & Bainard, L. D. (2022) · Soil Biology and Biochemistry · doi:10.1016/j.soilbio.2022.108858 · Cited by 51
Metadata
- Authors
- Charlton, J. R., Portilla, D., & Okusa, M. D.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-02
- Volume
- 29
- Issue
- 7
- Pages
- 1301-1311
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2101792171
- Cited by
- 286
- References
- 100
- FWCI
- 20.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.